Global Direct-to-consumer Genetic Testing Market 2017-2021


Report ID : RC-1029 Category : Healthcare Published Date : Sep-18
Publisher : Report Consultant Pages : 117 Format : PDF
Global Direct-to-consumer Genetic Testing Market 2017-2021

About Direct-to-consumer Genetic Testing

DTC genetic testing is a service that is offered by companies, retail, and clinical diagnostic laboratories directly to the consumer. DTC genetic testing services are marketed to consumers through television and print and online advertisements. DTC genetic testing is widely adopted owing to increasing awareness about gene sequencing for the early detection of diseases. However, in many countries, companies also conduct gene sequencing for matchmaking, to ascertain ancestry, and to check the vitamin level in the body.Technavio?s analysts forecast the global direct-to-consumer genetic testing market to grow at a CAGR of 11.68% during the period 2017-2021.

Covered in this report 

The report covers the present scenario and the growth prospects of the global direct-to-consumer genetic testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of DTC genetic testing services. It does not include the cost of test kits and shipping charges.The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Direct-to-consumer Genetic Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors
23andMe
LabCorp
Myriad Genetics
Quest Diagnostics
Other prominent vendors
African Ancestry
Alpha Biolaboratories
Ambry Genetics
AncestrybyDNA
Anglia DNA Services
Canadian DNA Services
Centrillion Technology
Color Genomics
Counsyl
Dante Labs
DNA Diagnostics Center
DNA Family Check
DNA4Life
DNA Services of America
EasyDNA
Full Genomes
24genetics
Gene By Gene
GHC GENETICS
Genetic Health
IDENTIGENE
IntelliGenetics
Invitae
Living DNA
Mapmygenome
MyHeritage
Pathway Genomics
Positive Bioscience
SureGenomics
Shuwen Health Sciences
Sonora Quest Laboratories
Test Me DNA
VCGS
Walk-In Lab
Xcode
Market driver
Chronic disorders in adult population
For a full, detailed list, view our report
Market challenge
Strict guidelines by FDA and FTC in US
For a full, detailed list, view our report
Market trend
Development of online applications to serve customer needs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Press Releases

Technavio Announces the Publication of its Research Report ? Global Direct-to-consumer Genetic Testing Market 2017-2021

Technavio recognizes the following companies as the key players in the global direct-to-consumer genetic testing market: 23andMe, LabCorp, Myriad Genetics, and Quest Diagnostics

Other Prominent Vendors in the market are: African Ancestry, Alpha Biolaboratories, Ambry Genetics, AncestrybyDNA, Anglia DNA Services, Canadian DNA Services, Centrillion Technology, Color Genomics, Counsyl, Dante Labs, DNA Diagnostics Center, DNA Family Check, DNA4Life, DNA Services of America, EasyDNA, Full Genomes, 24genetics, Gene By Gene, GHC GENETICS, Genetic Health, IDENTIGENE, IntelliGenetics, Invitae, Living DNA, Mapmygenome, MyHeritage, Pathway Genomics, Positive Bioscience, SureGenomics, Shuwen Health Sciences, Sonora Quest Laboratories, Test Me DNA, VCGS, Walk-In Lab, and Xcode.

Commenting on the report, an analyst from Technavio?s team said: ?The latest trend gaining momentum in the market is Development of online applications to serve customer needs. To compete with existing companies, new entrants are developing applications that can help them reach out to physicians. The growing adoption of Android has increased the adoption of applications such as KolGene, which acts as a mediator between physicians and clinical laboratories. Hence, Helix, a subsidiary of Illumina, will become a competitor for Tier 1 DTC genetic testing companies such as 23andMe and Quest Diagnostics. Illumina?s continuous focus to develop advanced next-generation sequencers and its brand recognition can increase the adoption of Helix in the future.?

According to the report, one of the major drivers for this market is Chronic disorders in adult population. People between the ages of 18 to 49 are susceptible to chronic diseases such as cardiovascular diseases (CVDs) and type 2 diabetes. A study conducted by the CDC in 2016 found that in 2012, around 117 million adults were suffering from one or more chronic diseases such as heart disease or cancer. A combined study conducted by the Section of General Internal Medicine at the VA Boston Healthcare System and other institutions in 2013 on 521 adults found that respondents who had high phenotypic diabetic risk were aware of genetic testing.

Further, the report states that one of the major factors hindering the growth of this market is Strict guidelines by FDA and FTC in US. To order a DTC genetic test, people need not provide information related to their medical history, pre- and post-test counseling, or other medical components. DTC genetic testing provides results with the possibility of developing gene-related diseases in the future. Hence, there is no direct connection between people and genetic counselors. Also, the Government of the US has observed that there is high adoption of DTC genetic testing in the country, which encouraged the FDA to develop strict guidelines to regulate DTC genetic testing to increase patient safety. In November 2015, the FDA sent warning letters to few companies based on tests. 
Executive summary
Scope of the report
Research Methodology
Introduction
Overview
DTC genetic testing
Table DTC genetic testing process
Market landscape
Overview
Table Limitations of DTC genetic testing and key focus of companies
Market size and forecast
Table Global DTC genetic testing market 2016-2021 ($ million)
Table Adoption of DTC genetic testing and average cost of preferred tests
Five forces analysis
Table Five forces analysis
Segmentation by service
Table DTC genetic testing services: Adoption
Table Global DTC genetic testing market: Segmentation by service 2016
Diagnostic screening
Table Diagnostic screening using DTC genetic testing: Purpose, companies that offer services, and price
Table Diagnostic screening using DTC genetic testing: Overview
Table Diagnostic screening using DTC genetic testing: Market insights
Prenatal, newborn screening, and preimplantation diagnosis
Table Prenatal, newborn screening, and pre-implantation diagnosis using DTC genetic testing services: Overview
Table Prenatal, newborn screening, and pre-implantation diagnosis: Market insights
Relationship testing
Table Relationship testing using DTC genetic testing services: Overview
Segmentation by channel
Overview
Table Global DTC genetic testing market: Segmentation by distribution channel 2016 (% share)
Direct sales
Table DTC genetic testing through direct sales: Overview
Table Direct sales: Market impact analysis
Clinical laboratories
Table DTC genetic testing companies and laboratories: Consumer approach
Table Clinical laboratories: Regulatory paradigm analysis
Retail sales
Table Retail sales of paternity tests: Overview
Segmentation by geography
Table Global DTC genetic testing market: Segmentation by geography 2016 and 2021 ($ million)
Americas
Table DTC genetic testing market in Americas: Overview
Table DTC genetic testing market in Americas 2016-2021 ($ million)
Table DTC genetic testing market based on countries in Americas: Analysis
Table DTC genetic testing in US: Overview
Table Role of regulatory in genetic tests and services in US
Table DTC genetic testing in US: Market dynamics
EMEA
Table Legislations related to DTC genetic testing in European countries
Table Hospital admissions for diabetes in EMEA 2008 and 2013 (per 10,000 people)
Table DTC genetic testing in EMEA: Overview
Table DTC genetic testing market in EMEA 2016-2021 ($ million)
Table DTC genetic testing market based on countries in EMEA: Analysis
Table DTC genetic testing in UK: Overview
Table DTC genetic testing in UK: Market dynamics
APAC
Table DTC genetic testing in APAC: Overview
Table DTC genetic testing market in APAC 2016-2021 ($ million)
Table DTC genetic testing market based on countries in EMEA: Analysis
Decision framework
Drivers and challenges
Market drivers
Table Growth of aging population aged 55 or more 2010-2050 (%)
Table Sick leaves among people aged between 50 and 59 years in European countries due to chronic diseases 2013 (days)
Table Clinical studies on DTC genetic testing awareness and market impact analysis
Table Partnership models
Market challenges
Table Price difference in hereditary breast cancer testing
Table FDA warning letters to companies
Market trends
Paradigm shift in business models
Table Business models of DTC genetic testing companies
Next-generation sequencing and biochip for present and future genetic diagnosis
Development of online applications to serve customer needs
Table Applications and insights
Vendor landscape
Competitive landscape
Table Competitive structure analysis of global DTC genetic testing market 2016
Table Competitive landscape analysis of global DTC genetic testing market 2016
Table Strategic recommendations for new entrants
Table Key recommendations for companies in the global DTC genetic testing market
Key vendor analysis
23andMe
Table 23andMe: Key highlights
Table 23andMe: Strength assessment
Table 23andMe: Strategy assessment
Table 23andMe: Opportunity assessment
LabCorp
Table LabCorp: Key highlights
Table LabCorp: Strength assessment
Table LabCorp: Strategy assessment
Table LabCorp: Opportunity assessment
Myriad Genetics
Table Myriad Genetics: Key highlights
Table Myriad Genetics: Strength assessment
Table Myriad Genetics: Strategy assessment
Table Myriad Genetics: Opportunity assessment
Quest Diagnostics
Table Quest Diagnostics: Key highlights
Table Quest Diagnostics: Strength assessment
Table Quest Diagnostics: Strategy assessment
Table Quest Diagnostics: Opportunity assessment
Other prominent vendors
Table Other prominent vendors
Appendix
List of abbreviations

Sidebar Menu